CD22 and bacterial infectious disease: We conclude that both after S. pneumoniae and E. coli infections CD22-/- mice have an impaired IRA B cell population in the lung, with impaired GM-CSF and IgM production, and therefore lack an important mechanism for protection against bacterial infections.